Andrade R, Tanajura D, Santana D, Santos DD, Carvalho EM (2013) Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy. Int Braz J Urol 39:861–866. https://doi.org/10.1590/S1677-5538.IBJU.2013.06.13

Article  PubMed  Google Scholar 

Araujo AQC, Silva MTT (2006) The HTLV-1 neurological complex. Lancet Neurol 5:1068–1076. https://doi.org/10.1016/S1474-4422(06)70628-7

Article  CAS  PubMed  Google Scholar 

Araújo A, Wedemann D (2019) HTLV-1 Associated Neurological Complex. What is Hidden below the Water? Aids Reviews 21

Google Scholar 

Bravo FG (2020) Infective dermatitis: a purely cutaneous manifestation of HTLV-1 infection. Semin Diagn Pathol 37:92–97. https://doi.org/10.1053/j.semdp.2019.04.002

Article  PubMed  Google Scholar 

Carneiro-Proietti ABF, Ribas JGR, Catalan-Soares BC, Martins ML, Brito-Melo GEA, Martins-Filho OA, Pinheiro SR, Araújo A, de Q-C, Galvão-Castro B, de Oliveira MSP, Guedes AC, Proietti FA (2002) Infecção E doença pelos vírus linfotrópicos humanos de células T (HTLV-I/II) no Brasil. Rev Soc Bras Med Trop 35:499–508. https://doi.org/10.1590/S0037-86822002000500013

Article  PubMed  Google Scholar 

Castro-Costa CMD, Araújo AQC, Barreto MM, Takayanagui OM, Sohler MP, Silva ELMD, Paula SMBD, Ishak R, Ribas JGR, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP (2006) Proposal for Diagnostic Criteria of Tropical Spastic Paraparesis/HTLV-I-Associated Myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 22:931–935. https://doi.org/10.1089/aid.2006.22.931

Article  PubMed  Google Scholar 

Cooper SA, van der Loeff MS, Taylor GP (2009) The neurology of HTLV-1 infection. Pract Neurol 9:16–26. https://doi.org/10.1136/jnnp.2008.167155

Article  PubMed  Google Scholar 

Dixon L, McNamara C, Dhasmana D, Taylor GP, Davies N (2023) Imaging Spectrum of HTLV-1–Related neurologic disease. Neurol Clin Pract 13:e200147. https://doi.org/10.1212/CPJ.0000000000200147

Article  PubMed  PubMed Central  Google Scholar 

Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y (1992) Primary Sjögren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51:769–776

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eguchi K, Origuchi T, Takashima H, Iwata K, Katamine S, Nagataki S (1996) High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis. Arthritis Rheum 39:463–466. https://doi.org/10.1002/art.1780390314

Article  CAS  PubMed  Google Scholar 

Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ (2019) HTLV-1 infection: an emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter 32:485–496

CAS  PubMed  PubMed Central  Google Scholar 

Gessain A, Cassar O (2012) Epidemiological aspects and World distribution of HTLV-1 infection. Front Microbiol 3. https://doi.org/10.3389/fmicb.2012.00388

Gessain A, Vernant JC, Maurs L, Barin F, Gout O, Calender A, De Thé G (1985) Antibodies to human T-Lymphotropic virus Type-I in patients with tropical spastic paraparesis. Lancet 326:407–410. https://doi.org/10.1016/S0140-6736(85)92734-5

Article  Google Scholar 

Giam C-Z (2021) HTLV-1 replication and adult T cell Leukemia Development. In: Wu T-C, Chang M-H, Jeang K-T (eds) Viruses and Human Cancer: from Basic Science to Clinical Prevention. Springer International Publishing, Cham, pp 209–243

Chapter  Google Scholar 

Haziot ME, Gascon MR, Assone T, Fonseca LAM, Luiz ODC, Smid J, Paiva AM, Marcusso RM, de Oliveira AP, Casseb J (2019) Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load. PLoS Negl Trop Dis 13:e0006967. https://doi.org/10.1371/journal.pntd.0006967

Article  PubMed  PubMed Central  Google Scholar 

Imamura A, Kitagawa T, Ohi Y, Osame M (1991) Clinical manifestation of human T-cell lymphotropic virus type-I-associated myelopathy and vesicopathy. Urol Int 46:149–153. https://doi.org/10.1159/000282121

Article  CAS  PubMed  Google Scholar 

King-Robson J, Hampton T, Rosadas C, Taylor GP, Stanton B (2022) HTLV-1 encephalitis. Pract Neurol 22:60–63. https://doi.org/10.1136/practneurol-2021-003053

Article  PubMed  Google Scholar 

KoboToolbox. In: KoboToolbox. https://www.kobotoolbox.org/. Accessed 5 Nov 2023

La Grenade L, Manns A, Fletcher V, Carberry C, Hanchard B, Maloney EM, Cranston B, Williams NP, Wilks R, Kang EC, Blattner WA (1998) Clinical, pathologic, and immunologic features of human T-Lymphotrophic virus type I–Associated Infective Dermatitis in Children. Arch Dermatol 134:439. https://doi.org/10.1001/archderm.134.4.439

Article  PubMed  Google Scholar 

Leclercq M, Sauvêtre G, Levesque H, Marie I (2015) [Recurrent facial palsy revealing human T-lymphotropic virus type 1 (HTLV-1) infection]. Rev Med Interne 36:701–705. https://doi.org/10.1016/j.revmed.2014.11.013

Article  CAS  PubMed  Google Scholar 

Mochizuki M, Watanabe T, Yamaguchi K, Tajima K, Yoshimura K, Nakashima S, Shirao M, Araki S, Miyata N, Mori S (1992) Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis 166:943–944. https://doi.org/10.1093/infdis/166.4.943

Article  CAS  PubMed  Google Scholar 

Nakamura T (2023) HAM/TSP pathogenesis: the transmigration activity of HTLV-1-Infected T cells into tissues. Pathogens 12:492. https://doi.org/10.3390/pathogens12030492

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura T, Nishiura Y, Eguchi K (2009) Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Cent Nerv Syst Agents Med Chem 9:137–149. https://doi.org/10.2174/187152409788452090

Article  CAS  PubMed  Google Scholar 

Nascimento OJM, Marques W (2013) Chap. 30 - human T-cell leukemia virus (HTLV)-associated neuropathy. In: Said G, Krarup C (eds) Handbook of clinical neurology. Elsevier, pp 531–541

Google Scholar 

Ohbo K, Sugamura K, Sekizawa T, Kogure K (1991) Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy. Neurology 41:594–595. https://doi.org/10.1212/wnl.41.4.594

Article  CAS  PubMed  Google Scholar 

Piai Ozores D, Rathsam Pinheiro R, Boa-Sorte N, Campos E, Silva Dias M, Silva Lima R, Hialla Almeida Araújo T, Galvão-Castro B, Grassi MFR (2023) Prevalence and characteristics of HTLV-associated uveitis in patients from Bahia, an endemic area for HTLV – 1 in Brazil. Virol J 20:185. https://doi.org/10.1186/s12985-023-02135-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415–7419. https://doi.org/10.1073/pnas.77.12.7415

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prates G, Assone T, Corral M, Baldassin MPM, Mitiko T, Silva Sales FC, Haziot ME, Smid J, Fonseca LAM, de Toledo Gonçalves F, Penalva F, de Oliveira AC, Casseb J (2021) Prognosis Markers for Monitoring HTLV-1 Neurologic Disease. Neurol Clin Pract 11:134–140. https://doi.org/10.1212/CPJ.0000000000000866

Article  PubMed  PubMed Central  Google Scholar 

Ratner L (2022) A role for an HTLV-1 vaccine? Front Immunol 13:953650. https://doi.org/10.3389/fimmu.2022.953650

Article  CAS  PubMed  PubMed Central  Google Scholar 

Romanelli LCF, Miranda DM, Carneiro-Proietti ABF, Mamede M, Vasconcelos HMM, Martins ML, Ferreira ASD, Rosa DVF, Paula JJ, Romano-Silva MA, Nicolato R (2018) Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1). PLoS Negl Trop Dis 12:e0006720. https://doi.org/10.1371/journal.pntd.0006720

Article  PubMed  PubMed Central  Google Scholar 

Rosa DV, Magno LA, Pereira NC, Romanelli LC, Albuquerque MR, Martins ML, De Freitas Carneiro Proietti AB, Nicolato R, Simões E, Silva AC, De Miranda DM (2018) Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals. Biomark Med 12:447–454. https://doi.org/10.2217/bmm-2017-0313

Article  CAS  PubMed  Google Scholar 

Rosadas C, Taylor GP (2022) HTLV-1 and co-infections. Front Med (Lausanne) 9:812016. https://doi.org/10.3389/fmed.2022.812016

Article  PubMed  Google Scholar 

Rosadas C, Assone T, Yamashita M, Adonis A, Puccioni-Sohler M, Santos M, Paiva A, Casseb J, Oliveira ACP, Taylor GP (2020) Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: the impact of a neglected disease on the quality of life. PLoS Negl Trop Dis 14:e0008761. https://doi.org/10.1371/journal.pntd.0008761

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santana CS, Andrade F, da Silva GC, Nascimento JO, de Campos S, Giovanetti RF, Santos M, Gois LA, Alcantara LL, Barreto LCJ FK (2023) Advances in preventive vaccine development against HTLV-1 infection: a systematic review of the last 35 years. Front Immunol 14:1073779. https://doi.org/10.3389/fimmu.2023.1073779

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva TR, Rocha Santos MA, Macedo de Resende L, Labanca L, Caporali JF, de Scoralick Dias M, Utsch Gonçalves RT D (2020) Vestibular evoked myogenic potential on ocular, cervical, and Soleus Muscles to assess the extent of neurological impairment in HTLV-1 infection. Front Neurol 11:433. https://doi.org/10.3389/fneur.2020.00433

Article  PubMed  PubMed Central  Google Scholar 

Souza LS, Lins-Si